VERACYTE, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $517.1M | $445.8M | $361.1M | $296.5M | $219.5M |
| Gross profit | $362.5M | $298.1M | $229.7M | $175.7M | — |
| Research and development | $70.8M | $69.3M | $57.3M | $40.6M | $29.8M |
| Operating income | $57.8M | $16.1M | -$85.8M | -$41.1M | -$81.9M |
| Pretax income | $68.2M | $25.7M | -$76.6M | -$36.4M | -$81.6M |
| Income tax expense | $1.8M | $1.6M | -$2.2M | $133,000 | -$6.1M |
| Net income | $66.4M | $24.1M | -$74.4M | -$36.6M | -$75.6M |
| Balance Sheet | |||||
| Cash and equivalents | $362.6M | $239.1M | $216.5M | $154.2M | $173.2M |
| Current assets | $488.4M | $372.3M | $285.6M | $248.6M | $243.1M |
| Total assets | $1.4B | $1.3B | $1.1B | $1.2B | $1.2B |
| Current liabilities | $59.9M | $78.6M | $61.2M | $62.6M | $64.2M |
| Total liabilities | $96.4M | $124.1M | $70.8M | $81.2M | $91.3M |
| Stockholders' equity | $1.3B | $1.2B | $1.0B | $1.1B | $1.1B |
| Cash Flow Statement | |||||
| Cash from operations | $136.3M | $75.1M | $44.2M | $7.5M | -$31.6M |
| Depreciation and amortization | $21.4M | $23.5M | $27.2M | $25.9M | $19.6M |
| Stock-based compensation | $43.6M | $36.2M | $33.1M | $26.7M | $22.5M |
| Capital expenditure | $9.7M | $11.3M | $10.0M | $8.5M | $5.4M |
| Free cash flow | $126.6M | $63.8M | $34.3M | -$1.0M | -$37.0M |
| Impairments | $20.5M | $3.4M | $68.3M | $3.3M | $0 |
Shares outstanding 79.8M · Free float 98.4%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.